Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo
Total, all-cause mortality	Atacicept 25 mg
Total, all-cause mortality	Atacicept 75 mg
Total, all-cause mortality	Atacicept 150 mg
Total, other adverse events	Placebo	15	62
Total, other adverse events	Atacicept 25 mg	25	66
Total, other adverse events	Atacicept 75 mg	16	62
Total, other adverse events	Atacicept 150 mg	26	64
Total, serious adverse events	Placebo	3	62
Total, serious adverse events	Atacicept 25 mg	9	66
Total, serious adverse events	Atacicept 75 mg	8	62
Total, serious adverse events	Atacicept 150 mg	5	64

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00430495/event-totals